Wegener's granulomatosis (WG) is an autoimmune, necrotizing granulomatous disease of unknown aetiology that affects small and medium blood vessels, and is usually recurrent. Infection is the most frequent cause of death in patients with WG. A case of WG with pulmonary fungal infection in a 50-year-old man is reported. The patient was hospitalized following a 2-month history of haemoptysis and a 1-month history of intermittent fever. Examination and pathology results confirmed a diagnosis of WG with associated pulmonary fungal infection. The patient's condition was complicated by a septic pneumothorax and sinus formation after lung biopsy, and preexisting diabetes and hypertension, which worsened rapidly due to his critical condition. He was treated with glucocorticoids and cyclophosphamide therapy with the goal of controlling these complications, and had no recurrence within the 4-year follow-up period. This case demonstrated the utility of combined glucocorticoid and cyclophosphamide therapy for the treatment of infection in WG.
Introduction
Wegener's granulomatosis (WG) is characterized by multisystem granulomatous inflammation and necrotizing vasculitis. The lung is the most commonly affected organ in WG, with evidence of involvement in over 90% of patients during the course of their disease; in 9% of patients the lung is the only organ affected. 1 Steroid hormones and immunosuppressive therapy have an important impact on the prognosis of WG. 2 Relapse is common, with 50% of patients relapsing within 5 years. 2 WG with pulmonary fungal infection is less commonly described. Here, the case of a patient with WG and concomitant fungal infection is reported.
Case report
Appropriate approval was received from the Ethical Review Committee of Tongji University, Shanghai, China, and written consent was obtained from the patient. The patient was a 50-year-old male, hospitalized on 31 July 2006 for a cough that had been producing blood-tinged sputum for > 2 months; he had also been experiencing intermittent, morning-predominant fevers Y He, J Liu, B Gao et al. A case of WG with pulmonary fungal infection for 1 month. The patient's maximum temperature in the month prior to admission was 38.5°C, at which point he was directed to the local hospital (specific location unknown). A computed tomography (CT) scan of the chest revealed multiple nodules on the patient's lungs with many enlarged lymph nodes along the mediastinum porta pulmonis (lung hilum). The patient was treated with the antibiotics cefuroxime 1.5 g/day and levofloxacin 0.4 g/day for 2 weeks, followed by azithromycin 0.5 g/day and amoxicillin 2 g/day for 2 weeks (all administered via an intravenous [i.v.] route). He was subsequently transferred to Shanghai Pulmonary Hospital when he showed no significant improvement. The patient's medical history indicated that he had a 2-year history of chronic rhinitis (without regular treatment), and type 2 diabetes and hypertension for 2 years; control of blood glucose levels and blood pressure were irregular.
On physical examination, the patient had a temperature of 37.5°C, a heart rate of 80 beats/min, and a respiratory rate of 21 breaths/min; his blood pressure was 130/70 mmHg and his weight was 80 kg. He was breathing comfortably and had a symmetrical thorax. Vocal fremitus was slightly weakened on the right, and voiceless sounds were observed from both lungs through percussion. Breath sounds on the right were decreased and a few rales were audible, while breath sounds on the left were coarse. The heart had a regular rate and rhythm with no murmurs, rubs or gallops. The abdomen was soft without masses, tenderness on palpation or rebound tenderness. There was no clubbing.
Clinical and laboratory data were obtained on admission and during the patient's treatment (Table 1) . Laboratory tests undertaken on admission included arterial blood gas analysis with a pH of 7.48, a carbon dioxide partial pressure of 34 mmHg and an oxygen partial pressure of 75 mmHg. On the complete blood count, haemoglobin was 106.0 g/l, the red blood cell count was 4.1 × 10 12 /l, and the white blood cell count was 8.3 × 10 9 /l with an 82.0% neutrophil ratio (Table 1) . A urine analysis was positive for trace protein and trace occult blood. Markers of inflammation were elevated, with a C-reactive protein level of 54.0 mg/l and an erythrocyte sedimentation rate of 88.0 mm/h. The fasting blood glucose was 10.2 mmol/l. Immuno globulin G was 17.1 g/l, complement C3 was 2.1 g/l, and complement C4 was 0.5 g/l. The tuberculosis antibody was positive. Measured tumour markers included a CY211 of 18.7 ng/ml. The latex agglutination test was positive (determination of 1:1280). The serum galactomannan level (measured by optical density) was 2.1. From the rheumatoid fullanalysis set, the patient was positive for antiproteinase-3 antibody. Liver and renal function tests were within normal limits. Mycoplasma, chlamydia and legionella antibodies were negative, and allergen detection was negative. Sputum and bronchoscopic brush biopsy were negative for pathological cells and acid-fast bacilli. Sputum fungal culture grew Candida albicans 3+ and Aspergillus (Table 1) .
Pulmonary function testing demonstrated a serious decline in lung function with characteristics of restrictive lung disease. The ratio of residual gas and the total residual volume was increased. The diffusion capacity was significantly decreased, while airway resistance was slightly increased. The fluorodeoxyglucose scan demonstrated that both lungs had diffused multiple shadows. (Fig. 4) .
After extensive medical examinations and studies, the pulmonary shadows were diagnosed as WG with associated pulmonary fungal infection. The right middle meatal tissue pathology was also consistent with WG 
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prevention of infection (all initiated on 18 August 2006) were continued and the following drugs were added to the regimen: methylprednisolone 480 mg/day i.v., cyclophosphamide 200 mg orally every other day and cotrimoxazole 960 mg/day (trimethoprim 160 mg + sulphamethoxazole 800 mg) orally. The patient also commenced prednisone 80 mg/day orally 3 days later. Symptoms were improved after 1 month of therapy. At this time, a prednisone taper was initiated with a 5 mg dose reduction per week, the cyclophosphamide dose was decreased to 80 mg/day and the cotrimoxazole was discontinued. A repeat CT scan of the chest in January 2007 showed focal absorption (Fig.  6) . The patient was discharged from hospital and completed the prednisone taper over 2 months. The patient continued cyclophosphamide until October 2008, at which point a cyclophosphamide taper was started, reducing the dose by 25 mg every 3 months until it was completely stopped in October 2009. A follow-up CT of the chest in December 2010 showed excellent focal absorption. There was no recurrence at that time or at any subsequent reviews (Fig. 7) .
Discussion
Wegener's granulomatosis is a necrotizing granulomatous disease of unknown aetiology that affects small and medium blood vessels. It is considered to be an autoimmune disease, but its pathogenesis is unclear. While WG mainly affects the upper and lower respiratory tract and the kidneys, it can also involve the eyes, ears, heart, skin, peripheral and central nervous system, joints and other organs. 3 -9 Published reports indicate that the incidence of WG is approximately 10 cases per 1 million people and it is slightly more common in males than 
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in females, 10 although there are no published data on the incidence of WG in China. While this disease may affect patients of any age, men from 40 to 50 years of age have the highest incidence 11 -13 and the lungs are affected in 75 -95% of WG cases. 11, 14 WG is often misdiagnosed as tuberculosis, pneumonia, lung tumours and other diseases. If lung disease does not respond to appropriate treatment, physicians should consider the possibility of WG.
Early diagnosis and treatment can improve not only patient survival, but also comfort and quality of life. 15 Detection of serum antineutrophil cytoplasmic antibodies and their associated target antigens, and antiproteinase-3 antibody, 16 -19 along with sinus and chest CT, 20, 21 upper respiratory tract, endobronchial, sinus and kidney biopsies, are important diagnostic tests. 22, 23 Abnormal imaging features in the lung are the result of immunologically-mediated necrotizing vasculitis. The most common manifestation of lung involvement is the presence of nodules. Other imaging manifestations include lung consolidation with ground-glass opacities, mosaic attenuation, tree-in-bud opacities, and interlobular septal thickening. 24 -26 When the diagnosis is difficult, thoracoscopy or thoracotomy biopsy may be advisable. 27 Nonspecific inflammation with scattered multinucleated giant cells, granulomas and tissue necrosis associated with vasculitis are the most common pathological changes of WG. 11 These can be highly suggestive for its diagnosis, although these pathological changes can also occur occasionally in FIGURE 6: Computed tomography scan of the chest of a 50-year-old male diagnosed with Wegener's granulomatosis after hospitalization for persistent productive cough and intermittent morning-predominant fever. The scan was performed after the patient had taken steroid hormone and immunosuppressant therapy, combined with antifungal treatment, between August 2006 and January 2007. After biopsy the patient developed emphysema on the right. Irregular patch strip cable shadow combined with a small branch expansion could be seen in right middle upper lung. The gas was packaged in the right pleura, the right pleural film was thickened and had adhesions, and the right side had subcutaneous emphysema. The patch shadows on the right lung were absorbed compared with the previous scan, the gas in the right side was reduced and the right chest wall sinus was closed basally Y He, J Liu, B Gao et al.
tuberculosis, fungal infections and other diseases. 28 The clinical management of WG can be divided into three stages: induction of remission; maintenance of remission; control of recurrence. Reports show that the 5-year relapse rate for WG is high. 29 Corticosteroid and cyclophosphamide combination therapy has a significant effect and should be the preferred treatment. 30 -34 Currently, the prognosis of untreated patients with WG is considered to be poor and 90% of untreated patients die within 2 years. 11 In particular, the severity of the condition in antiproteinase-3 antibody-positive patients progresses rapidly without treatment. 35 It is generally accepted that patients with WG who are of older age, with renal involvement or infection, have worse outcomes and higher mortality rates compared with other patients who develop WG. 36 -40 Infection is the most frequent cause of death. 41 Finding the balance between the level of immunosuppression needed to treat WG and minimizing the risk of bacterial infection is the most complicated issue in the management of WG patients. The present patient's condition was complicated by a concomitant fungal infection and additional morbidities that occurred subsequent to the medical evaluation. This patient underwent successful combined immunosuppression and antifungal therapy without recurrence during a 4-year follow-up period. In the treatment of WG, particularly when the clinical picture is complex, the combined use of glucocorticoids and cyclophosphamide should be considered.
Wegener's granulomatosis is a rare disease that can affect multiple organs with varied penetrance, but it lacks distinctive clinical features, making the correct diagnosis difficult. If the disease is not treated early, the patient's prognosis is poor. As shown by the case presented here, the pathology offers limited information for a correct diagnosis of WG. If WG is on the 
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